Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years Post author:Sam Post published:September 14, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Otsuka Pharma Believes in Akebia, Commits Another $865 Million to Expand Anemia Deal April 25, 2017 Novartis AG Hires Bank of America to Officially Review Alcon Options April 20, 2017 No Doubt: This is the Top Gene-Sequencing Stock to Buy This Year April 20, 2017